Company Filing History:
1 out of 12 
1 out of 23 Years Active: 2003-2007
Title: Ingo Hardt: Innovator in Biotechnological Research
Introduction
Ingo Hardt is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of biotechnology, particularly through his innovative work on epothilones. With a total of 2 patents, Hardt's inventions have the potential to impact various applications in medicine and research.
Latest Patents
Ingo Hardt's latest patents focus on epothilone side components and minor constituents. The first patent concerns compounds that can be obtained by fermenting DSM 6773, specifically epothilones A1, A2, A8, A9, B10, C1, C2, C3, C4, C5, C6, C7, C8, C9, D1, D2, D5, G1, G2, H1, H2, I1, I2, I3, I4, I5, I6, and K, along with trans-epothilones C1 and C2. The second patent similarly relates to compounds obtained through the fermentation of DSM 6773, emphasizing the same epothilones.
Career Highlights
Throughout his career, Ingo Hardt has worked with prominent organizations in the biotechnology sector. He has been associated with the Gesellschaft für Biotechnologische Forschung mbH (GBF) and the Helmholtz-Zentrum für Infektionsforschung GmbH. His work in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.
Collaborations
Ingo Hardt has collaborated with esteemed colleagues such as Gerhard Hoefle and Hans Reichenbach. These partnerships have fostered a collaborative environment that enhances innovation and research in the field of biotechnology.
Conclusion
Ingo Hardt's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work on epothilones showcases the potential for advancements in medical applications.